Abstract
The aims of this study are to establish an embryonic stem (ES) cell model of polycystic ovary syndrome and to characterize this ES cell line. ES cells were isolated and cultured from 322 wasted fertilized embryos from polycystic ovary syndrome (PCOS) patients in vitro. They were also characterized by development and differential markers. ES cells from PCOS subject present normal development profile with ES-specific markers such as OCT-4 and SSEA-4. These ES cells can also differentiate into three germ layer derivatives and form teratomas in vivo. ES cells from PCOS patients pose development and differentiation potentials as you would expect of cells from non-PCOS patients; therefore, they can be used as a cellular model to study the pathology of PCOS.
References
Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, EscobarMorreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85(7):2434–38
Azziz R (2004) PCOS: a diagnostic challenge. Reprod Biomed Online 8:644–48
Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–49
Bhartiya D, Unni S, Parte S, Anand S (2013) Very small embryonic-like stem cells: implications in reproductive biology. BioMed Res Int 2013:682326
Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84(11):4006–11
Draper JS, Pigott C, Thomson JA, Andrews PW (2002) Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200(Pt 3):249–58
Fenderson BA, Andrews PW, Nudelman E, Clausen H, Hakomori S (1987) Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol 122(1):21–34
Fenderson BA, Zehavi U, Hakomori S (1984) A multivalent lacto-N-fucopentaose III-lysyllysine conjugate decompacts pre-implantation-stage mouse embryos, while the free oligosaccharide is ineffective. J Exp Med 160(5):1591–96
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219–31
Hurliman A, Keller Brown J, Maille N, Mandala M, Casson P, Osol G (2015) Hyperandrogenism and insulin resistance, not changes in body weight, mediate the development of endothelial dysfunction in a female rat model of polycystic ovary syndrome (PCOS). Endocrinology 156(11):4071–80
Khan KA, Stas S, Kurukulasuriya LR (2006) Polycystic ovarian syndrome. J Cardiometab Syndr 1(2):125–30
Lewandowski KC, Cajdler-Łuba A, Salata I, Bieńkiewicz M, Lewiński A (2011) The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS). Endokrynol Pol 62(2):120–8
Palomba S, Santagni S, Falbo A, La Sala GB (2015) Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health 31(7):745–63
Singh KB (2005) Persistent estrus rat models of polycystic ovary disease: an update. Fertil Steril 84(Suppl 2):1228–34
Wu S, Divall S, Nwaopara A, Radovick S, Wondisford F, Ko C, Wolfe A (2014) Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell. Diabetes 63(4):1270–82
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Zhang, Y., Zhang, Ys. & Xue, Fx. Characterization of embryonic stem cell model of polycystic ovary syndrome. In Vitro Cell.Dev.Biol.-Animal 52, 507–511 (2016). https://doi.org/10.1007/s11626-016-0040-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-016-0040-2